Background:
The Mediterranean diet is linked to various health benefits, especially the consumption of olive oil as a key component. Multiple studies highlight its advantages, particularly due to its fatty acid composition and additional components like phenolic compounds. A significant antioxidant compound, oleocanthal, known for its antioxidant properties, has gained attention in the pharmaceutical industry for its anti-inflammatory and antiproliferative effects. It shows promise in addressing cardiovascular diseases, metabolic syndrome, and neuroprotection. This systematic review aims to evaluate the existing literature on oleocanthal, examining its role in biological processes and potential impact on conditions like inflammation and cancer.
Methods:
We performed several searches in PubMed (MEDLINE), Web of Science (WOS), and Cochrane based on the terms "Oleocanthal", "Cancer", and "Inflammation". The inclusion criteria were as follows: studies whose main topics were oleocanthal and cancer or inflammation. On the other hand, the exclusion criteria were studies that were not focused on oleocanthal, reviews, or editorial material. Given that these findings are explanatory rather than derived from clinical trials, we refrained from employing methods to assess potential bias. This systematic review did not receive any external funding.
Results:
We found 174 records from these searches, where we discarded reviews and editorial material, duplicated articles, and 1 retracted article. Finally, we had 53 reports assessed for eligibility that were included in this review.
Discussion:
OC exhibits promising therapeutic potential against both inflammation and cancer. We addressed its ability to target inflammatory genes and pathways, offering potential treatments for conditions like rheumatic diseases by regulating pathways such as NF-kB and MAPK. Additionally, OC's anticancer properties, particularly its notable inhibition of c-Met signaling across various cancers, highlight its efficacy, showcasing promise as a potential treatment.
Citing Articles
New Insights in Natural Bioactive Compounds for Periodontal Disease: Advanced Molecular Mechanisms and Therapeutic Potential.
Hashim N, Babiker R, Chaitanya N, Mohammed R, Priya S, Padmanabhan V
Molecules. 2025; 30(4).
PMID: 40005119
PMC: 11858609.
DOI: 10.3390/molecules30040807.
Impact of Olive Oil Components on the Expression of Genes Related to Type 2 Diabetes Mellitus.
Munteanu C, Kotova P, Schwartz B
Nutrients. 2025; 17(3).
PMID: 39940428
PMC: 11820997.
DOI: 10.3390/nu17030570.
The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway.
Mahmud M, Siddique A, Tajmim A, King J, El Sayed K
Molecules. 2025; 30(1.
PMID: 39795195
PMC: 11721798.
DOI: 10.3390/molecules30010139.
Impact of a glutamine-enriched peptide formula on gastrointestinal toxicity and on the interruption of oncologic treatment in patients with adenocarcinoma of the rectum.
Salas-Salas B, Ferrera-Alayon L, Calleja-Fernandez A, Chicas-Sett R, Nogues-Ramia E, Zafra-Martin J
Front Nutr. 2025; 11:1414367.
PMID: 39758311
PMC: 11697424.
DOI: 10.3389/fnut.2024.1414367.
Effect of oleocanthal-rich olive oil on postprandial oxidative stress markers of patients with type 2 diabetes mellitus.
Katsa M, Gil A, Makri E, Papadogiannis S, Ioannidis A, Kalliostra M
Food Nutr Res. 2024; 68.
PMID: 39691690
PMC: 11650448.
DOI: 10.29219/fnr.v68.10882.
Evaluation of Sensorial Markers in Deep-Fried Extra Virgin Olive Oils: First Report on the Role of Hydroxytyrosol and Its Derivatives.
Mehany T, Gonzalez-Saiz J, Martinez J, Pizarro C
Foods. 2024; 13(23).
PMID: 39683025
PMC: 11641459.
DOI: 10.3390/foods13233953.
Nutritional and Nutraceutical Support to the Failing Myocardium: A Possible Way of Potentiating the Current Treatment of Heart Failure.
Macri R, Mollace R, Serra M, Scarano F, Ritorto G, Ussia S
Int J Mol Sci. 2024; 25(22).
PMID: 39596298
PMC: 11594499.
DOI: 10.3390/ijms252212232.
Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, L., in Long COVID and Other Conditions Involving Cognitive Impairment.
Papadopoulou P, Polissidis A, Kythreoti G, Sagnou M, Stefanatou A, Theoharides T
Int J Mol Sci. 2024; 25(20).
PMID: 39456822
PMC: 11507169.
DOI: 10.3390/ijms252011040.
Beneficial Effects of Tyrosol and Oleocanthal from Extra Virgin Olive Oil on Liver Health: Insights into Their Mechanisms of Action.
Gabbia D
Biology (Basel). 2024; 13(10).
PMID: 39452069
PMC: 11504303.
DOI: 10.3390/biology13100760.
Targeting PAR2-mediated inflammation in osteoarthritis: a comprehensive in vitro evaluation of oleocanthal's potential as a functional food intervention for chondrocyte protection and anti-inflammatory effects.
Patnaik R, Varghese R, Jannati S, Naidoo N, Banerjee Y
BMC Musculoskelet Disord. 2024; 25(1):769.
PMID: 39354427
PMC: 11446003.
DOI: 10.1186/s12891-024-07888-y.
Investigation of the Anti-Inflammatory Properties of Bioactive Compounds from : In Silico Evaluation of Cyclooxygenase Enzyme Inhibition and Pharmacokinetic Profiling.
Karagiannis T, Ververis K, Liang J, Pitsillou E, Kagarakis E, Yi D
Molecules. 2024; 29(15).
PMID: 39124908
PMC: 11314539.
DOI: 10.3390/molecules29153502.
Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?.
Seidita A, Cusimano A, Giuliano A, Meli M, Carroccio A, Soresi M
Antioxidants (Basel). 2024; 13(6).
PMID: 38929170
PMC: 11201095.
DOI: 10.3390/antiox13060731.
Proton-Coupled Electron Transfer and Hydrogen Tunneling in Olive Oil Phenol Reactions.
Toric J, Karkovic Markovic A, Mustac S, Pulitika A, Jakobusic Brala C, Pilepic V
Int J Mol Sci. 2024; 25(12).
PMID: 38928048
PMC: 11203655.
DOI: 10.3390/ijms25126341.
Hepatotoxicity assessment of innovative nutritional supplements based on olive-oil formulations enriched with natural antioxidants.
Prodromou S, Chatzopoulou F, Saiti A, Giannopoulos-Dimitriou A, Koudoura L, Pantazaki A
Front Nutr. 2024; 11:1388492.
PMID: 38812942
PMC: 11133736.
DOI: 10.3389/fnut.2024.1388492.
Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer.
Capuozzo M, Santorsola M, Ianniello M, Ferrara F, Zovi A, Petrillo N
Diseases. 2024; 12(5).
PMID: 38785742
PMC: 11119780.
DOI: 10.3390/diseases12050087.